Recent years have seen growing interest in the use of artificial intelligence tools for healthcare applications, including diagnosis, risk prediction,…
Pathalys Pharma, the Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new…
Following a year of record-breaking economic development successes, business and community leaders came together at the Raleigh Chamber’s annual meeting…